ReShape Lifesciences Inc. (RSLS) Expected earnings per share growth for next year
Sales of obesity treatment systems generate current revenue, as confirmed by analyst expectations for N+1 profit dynamics for ReShape Lifesciences (RSLS). The value of 0.00 expresses the metric's value today. Growth prospects are tied to the modernization of sensors and Lap-Band, however, logistical disruptions and sanctions limit the sale of medical equipment in several countries, creating serious risks for component supplies.
Analytical breakdowns for ReShape Lifesciences Inc. (RSLS)
- share price and consensus valuation forecast:
- market capitalization details:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital ReShape Lifesciences|RSLS - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital ReShape Lifesciences, Inc.|RSLS - Company Total Debt Obligations|Debts to Book Capitalization ReShape Lifesciences|RSLS - Company Long-Term Liabilities|Company Short-Term Debts ReShape Lifesciences|Quick Liquidity reshapelifesciences.com
- net income and valuation ratios data:
RSLS - Company Net Income|Future Profit ReShape Lifesciences|RSLS - Company Value to Net Income|Forward P/E Multiple ReShape Lifesciences, Inc.|RSLS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ReShape Lifesciences|RSLS - Operating profit before depreciation charges|Net earnings per share for the last 12 months ReShape Lifesciences|RSLS - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth reshapelifesciences.com|RSLS - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year ReShape Lifesciences
Initial company analysis:ReShape Lifesciences, RSLS
This indicator measures market consensus expectations for earnings per share growth rates, providing a real-time assessment of institutional capital reallocation in response to macroeconomic shocks. The current value of 0.00 reflects the market valuation of the commercialization potential for ReShape Lifesciences (RSLS) minimally invasive obesity treatment systems, allowing investors to evaluate the effectiveness of the new weight control technology implementation strategy via the forward EPS forecast for the coming year.
Analysis of competing companies
DXCM (Dexcom Corp) - Earnings growth forecast for next year|Expected earnings per share growth for next year Penumbra Medical (PEN)|Expected earnings per share growth for next year NOVT (Novanta Inc.)|HAE (haemonetics.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Inspire Medical Systems, Inc. INSP|PRCT - Expected earnings per share growth for next year|CONMED Corp. - Earnings growth forecast for next year|Expected net earnings per share growth next year Pulse Medical|INMD: Earnings growth forecast for next year|Projected earnings per share growth rate for next year PMI|SRDX (Surmodics) - Earnings growth forecast for next year|Senseonics Holdings Inc (SENS) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year NPCE|Expected earnings per share growth for next year tactilemedical.com TCMD|Earnings growth forecast for next year SNWV (Sanuwave Health Inc)|Earnings growth forecast for next year outsetmedical.com OM|ELMD - Net earnings per share growth forecast for next year|LNSR: Net earnings per share growth forecast for next year|RCEL (AVITA Medical, Inc) - Expected earnings per share growth for next year|Profound Medical - Expected earnings per share trend next year|BDMD (Baird Medical Investment Holdings) - Earnings growth forecast for next year|Expected net earnings per share growth next year EDAP Medical EDAP|Net earnings per share growth forecast for next year Apyx Medical (APYX)|icecure-medical.com (ICCM) - Net earnings per one share growth forecast for next year|Pulmonx - Expected earnings per share growth for next year|Earnings growth forecast for next year TELA Bio Inc. TELA|CytoSorbents Corp. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year sensushealthcare.com SRTS|Zynex (ZYXI) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year ECOR (electroCore)|Net earnings per share growth forecast for next year Vicarious Surgical Inc|Expected earnings per share growth for next year Inspira Technologies Oxy B.H.N. Ltd (IINN)|Earnings growth forecast for next year ICU|IRIX - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Intelligent Bio Solutions Inc. INBS|XAIR: Projected earnings per share growth rate for next year|PFSA: Expected earnings per share growth for next year|STRATA Skin Sciences - Projected earnings per share increase next year|GlucoTrack (GCTK) - Net earnings per share growth forecast for next year|NanoVibronix Inc. - Expected earnings per share trend next year|VERO (Venus Concept) - Earnings growth forecast for next year|Expected net earnings per share growth next year Nuwellis Inc NUWE|Net earnings per share growth forecast for next year Aethlon (AEMD)|Consensus forecast of earnings per share growth for next year asensus.com|Earnings growth forecast for next year AVGR (Avinger, Inc.)|Expected earnings per share trend next year BSGM|Cutera - Earnings growth forecast for next year|KNW - Earnings growth forecast for next year|Inari (NARI) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year NVRO (Nevro Medical)|SILK (Silk Road Medical, Inc) - Earnings growth forecast for next year
